The Venture Codex Logo

The Venture Codex

Overview

Biotech R&D services for first-in-class GPCR targeted drugs.

Total Raised

$238 M

Rounds

3

Links

Verticals

Biotechnology
Medical
Pharmaceutical
Therapeutics

Investment History

  1. Series C

    Nov 2022

    $120M

  2. Series B

    Sep 2020

    $78M

  3. Series A

    May 2018

    $40M

Team

Joshua Grass

Chief Executive Officer

Marcus Boehm

Chief Scientific Officer and Company Cofounder

James R. Schmidt

Vice President, Finance and Administration

Richard Pittner

Vice President and Head of Biology